Susan joined the Dementia Discovery Fund U.S. Discovery team in August 2019
Susan conducted search and evaluation for neurological indications as a member of the External Portfolio Innovation Unit at Biogen. Prior to this, she was a research scientist investigating potential therapeutic treatments for stroke and ALS in the Acute Neurology and Neuromuscular & Movement Disorders Research Units.
BS, Biology, Duke University; PhD, Cellular and Molecular Neurobiology, MIT; Postdoctoral fellowship, Harvard Medical School
The Company Creators